28 related articles for article (PubMed ID: 1444233)
1. Increased cell-surface receptor expression on U-937 cells induced by 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine.
Pushkareva MY; Wannberg SL; Janoff AS; Mayhew E
Cancer Immunol Immunother; 2000 Jan; 48(10):569-78. PubMed ID: 10630309
[TBL] [Abstract][Full Text] [Related]
2. 1-O-Octadecyl-2-O-methylglycerophosphocholine inhibits protein kinase C-dependent phosphorylation of endogenous proteins in MCF-7 cells.
Zhou X; Arthur G
Biochem J; 1997 Jun; 324 ( Pt 3)(Pt 3):897-902. PubMed ID: 9210414
[TBL] [Abstract][Full Text] [Related]
3. The differential susceptibility of A427 and A549 cell lines to the growth-inhibitory effects of ET-18-OCH3 does not correlate with the relative effects of the alkyl-lysophospholipid on the incorporation of fatty acids into cellular phospholipids.
Lu X; Arthur G
Cancer Res; 1992 May; 52(10):2813-7. PubMed ID: 1581895
[TBL] [Abstract][Full Text] [Related]
4. Correlation of ether lipid content of human leukemia cell lines and their susceptibility to 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine.
Chabot MC; Wykle RL; Modest EJ; Daniel LW
Cancer Res; 1989 Aug; 49(16):4441-5. PubMed ID: 2743333
[TBL] [Abstract][Full Text] [Related]
5. The antitumor ether lipid 1-Q-octadecyl-2-O-methyl-rac-glycerophosphocholine (ET-18-OCH3) inhibits the association between Ras and Raf-1.
Samadder P; Richards C; Bittman R; Bhullar RP; Arthur G
Anticancer Res; 2003; 23(3B):2291-5. PubMed ID: 12894505
[TBL] [Abstract][Full Text] [Related]
6. Perturbations of cellular acylation processes by the synthetic alkyl-lysophospholipid 1-O-octadecyl-2-O-methylglycero-3-phosphocholine do not correlate with inhibition of proliferation of MCF7 and T84 cell lines.
Lu X; Arthur G
Cancer Res; 1992 May; 52(10):2806-12. PubMed ID: 1581894
[TBL] [Abstract][Full Text] [Related]
7. Decreased sensitivity to 1-O-octadecyl-2-O-methyl-glycerophosphocholine in MCF-7 cells adapted for serum-free growth correlates with constitutive association of Raf-1 with cellular membranes.
Samadder P; Arthur G
Cancer Res; 1999 Oct; 59(19):4808-15. PubMed ID: 10519389
[TBL] [Abstract][Full Text] [Related]
8. The relationship between cellular ether glycerophospholipid content and sensitivity of cancer cells to 1-O-octadecyl-2-O-methyl-glycerophosphocholine.
Zhou X; Lu X; Arthur G
Anticancer Res; 1992; 12(5):1659-62. PubMed ID: 1444233
[TBL] [Abstract][Full Text] [Related]
9. Biological activities, mechanisms of action and biomedical prospect of the antitumor ether phospholipid ET-18-OCH(3) (edelfosine), a proapoptotic agent in tumor cells.
Gajate C; Mollinedo F
Curr Drug Metab; 2002 Oct; 3(5):491-525. PubMed ID: 12369895
[TBL] [Abstract][Full Text] [Related]
10. ET-18-OCH3 (edelfosine): a selective antitumour lipid targeting apoptosis through intracellular activation of Fas/CD95 death receptor.
Mollinedo F; Gajate C; MartÃn-SantamarÃa S; Gago F
Curr Med Chem; 2004 Dec; 11(24):3163-84. PubMed ID: 15579006
[TBL] [Abstract][Full Text] [Related]
11. Glycosylated antitumor ether lipids: activity and mechanism of action.
Arthur G; Bittman R
Anticancer Agents Med Chem; 2014 May; 14(4):592-606. PubMed ID: 24628233
[TBL] [Abstract][Full Text] [Related]
12. Alkyl-lysophospholipids as anticancer agents and enhancers of radiation-induced apoptosis.
Ruiter GA; Verheij M; Zerp SF; van Blitterswijk WJ
Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):415-9. PubMed ID: 11173135
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
